PHARMACOLOGICAL AND FUNCTIONAL-CHARACTERIZATION OF THE WILD-TYPE AND SITE-DIRECTED MUTANTS OF THE HUMAN H-1 HISTAMINE-RECEPTOR STABLY EXPRESSED IN CHO CELLS

被引:41
作者
MOGUILEVSKY, N [1 ]
VARSALONA, F [1 ]
GUILLAUME, JP [1 ]
NOYER, M [1 ]
GILLARD, M [1 ]
DALIERS, J [1 ]
HENICHART, JP [1 ]
BOLLEN, A [1 ]
机构
[1] UCB BIOPROD SA,PHARMA SECTOR,B-1420 BRAINE LALLEUD,BELGIUM
来源
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH | 1995年 / 15卷 / 1-4期
关键词
D O I
10.3109/10799899509045210
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cDNA clone for the human histamine H-1 receptor was isolated from a lung cDNA library and stably expressed in CHO cells. The recombinant receptor protein present in the cell membranes, displayed the functional and binding characteristics of histamine H-1 receptors. Mutation of Ser155 to Ala in the fourth transmembrane domain did not significantly change the affinity of the receptor for histamine and H-1 antagonists. However, mutation of the fifth transmembrane Asn198 to Ala resulted in a dramatic decrease of the affinity for histamine binding, and for the histamine induced polyphosphoinositides breakdown, whereas the affinity towards antagonists was not significantly modified. In addition, mutation of another fifth transmembrane amino acid, Thr194 to Ala also diminished, but to a lesser extent, the affinity for histamine. These data led us to propose a molecular model for histamine interaction with the human H-1 receptor. In this model, the amide moiety of Asn198 and the hydroxyl group of Thr194 are involved in hydrogen bonding with the nitrogen atoms of the imidazole ring of histamine. Moreover, mutation of Thr194 to Ala demonstrated that this residue is responsible for the discrimination between enantiomers of cetirizine.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 11 条
  • [1] AN M2 MUSCARINIC RECEPTOR SUBTYPE COUPLED TO BOTH ADENYLYL CYCLASE AND PHOSPHOINOSITIDE TURNOVER
    ASHKENAZI, A
    WINSLOW, JW
    PERALTA, EG
    PETERSON, GL
    SCHIMERLIK, MI
    CAPON, DJ
    RAMACHANDRAN, J
    [J]. SCIENCE, 1987, 238 (4827) : 672 - 675
  • [2] BEAVEN MA, 1984, J BIOL CHEM, V259, P7137
  • [3] BILLAH MM, 1990, J PHARMACOL EXP THER, V252, P1090
  • [4] BOLLEN A, Patent No. 93223535
  • [5] HETEROGENEITY OF HISTAMINE H1-RECEPTORS - SPECIES VARIATIONS IN [MEPYRAMINE-H-3 BINDING OF BRAIN MEMBRANES
    CHANG, RSL
    TRAN, VT
    SNYDER, SH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1979, 32 (06) : 1653 - 1663
  • [6] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [7] GENOMIC CLONING, HETEROLOGOUS EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HISTAMINE H1-RECEPTOR
    DEBACKER, MD
    GOMMEREN, W
    MOEREELS, H
    NOBELS, G
    VANGOMPEL, P
    LEYSEN, JE
    LUYTEN, WHML
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1601 - 1608
  • [8] GANTZ I, 1992, J BIOL CHEM, V267, P20840
  • [9] HIBERT MF, 1991, MOL PHARMACOL, V40, P8
  • [10] MOGUILEVSKY N, IN PRESS EUR J BIOCH